|
Urinary Kallikrein and Hypertension: A Prospective Study Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Urinary Kallikrein and Hypertension: A Prospective Study conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Urinary Kallikrein and Hypertension: A Prospective Study Clinical research trials and Urinary Kallikrein and Hypertension: A Prospective Study medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Urinary Kallikrein and Hypertension: A Prospective Study. Urinary Kallikrein and Hypertension: A Prospective Study Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Urinary Kallikrein and Hypertension: A Prospective Study clinical trial. Participants frequently obtain the most expert healthcare available for their Urinary Kallikrein and Hypertension: A Prospective Study condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "U" Clinical Trials Conditions > Urinary Kallikrein and Hypertension: A Prospective Study  Urinary Kallikrein and Hypertension: A Prospective Study
Urinary Kallikrein and Hypertension: A Prospective Study
For Condition: Heart Diseases,Cardiovascular Diseases,Hypertension
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine whether low total urinary kallikrein activity was prospectively associated with new hypertension onset or elevated blood pressures.
Details: BACKGROUND: Statistical evidence had been found for a dominant major gene segregating in large pedigrees for high urinary kallikrein levels protecting against hypertension which explained 51 percent of the variance of total urinary kallikrein (TUK). In normotensive adult and pediatric pedigree members, low urinary kallikrein activity was associated with a positive family history of hypertension, stroke, and/or coronary disease. DESIGN NARRATIVE: The presence of a previously reported dominant major gene inferred from segregation analysis of total urinary kallikrein activity (TUK) in selected pedigrees was verified on already collected frozen urine specimens. Subjects were rescreened to obtain measured nine year follow-up blood pressure data. Individuals were classified by assigned baseline TUK genotype and tested to determine whether low TUK was prospectively associated with new hypertension onset or elevated blood pressures. Because a major gene effect was implicated, available probes for the structural kallikrein gene or other related products regulating kallikrein were tested for genetic linkage to TUK levels. Correlations with over 600 variables measured at baseline in pedigrees and twins were tested to analyze the strong familiality of environment, refine the genetic analyses to better assign genotypes, and detect gene-environment interactions. All baseline variables except kallikrein, aldosterone, and prostaglandin measurements on frozen urine and follow-up blood pressure had already been collected. TUK may be a marker for a renal, cellular or other physiological abnormality influencing both TUK expression and susceptibility to hypertension. Therefore, the relationship of TUK to urinary aldosterone, prostaglandin E excretion and already measured urinary electrolytes, plasma renin activity, and baseline and reactive blood pressures was determined. Genetic segregation analyses were performed of the urinary variables and other variables closely associated with TUK.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: 1145;
Study Start Date: July 1990
Record last reviewed: May 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005261
Other Heart Diseases Studies:
1. Flavonoids and Cardiovascular Disease
2. Framingham Nutrition Studies
3. Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
4. Community Surveillance of Congestive Heart Failure
5. Hispanic and White Women's Cardiovascular Health
Related Studies:
Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Urinary Kallikrein and Hypertension: A Prospective Study
|
|
|
|
|
|
|
|
